SE7701187L - Nya piperazinderivat och sett att framstella desamma - Google Patents

Nya piperazinderivat och sett att framstella desamma

Info

Publication number
SE7701187L
SE7701187L SE7701187A SE7701187A SE7701187L SE 7701187 L SE7701187 L SE 7701187L SE 7701187 A SE7701187 A SE 7701187A SE 7701187 A SE7701187 A SE 7701187A SE 7701187 L SE7701187 L SE 7701187L
Authority
SE
Sweden
Prior art keywords
produce
way
same
piperazine derivatives
new piperazine
Prior art date
Application number
SE7701187A
Other languages
English (en)
Swedish (sv)
Inventor
R Cyrus
M Raschack
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of SE7701187L publication Critical patent/SE7701187L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7701187A 1976-02-07 1977-02-03 Nya piperazinderivat och sett att framstella desamma SE7701187L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
SE7701187L true SE7701187L (sv) 1977-08-08

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701187A SE7701187L (sv) 1976-02-07 1977-02-03 Nya piperazinderivat och sett att framstella desamma

Country Status (25)

Country Link
US (1) US4079137A (cs)
JP (1) JPS52105186A (cs)
AT (1) AT355578B (cs)
AU (1) AU504526B2 (cs)
BE (1) BE850492A (cs)
CA (1) CA1094560A (cs)
CH (1) CH631448A5 (cs)
CS (1) CS201544B2 (cs)
DD (1) DD128133A5 (cs)
DE (1) DE2604845A1 (cs)
DK (1) DK138891C (cs)
ES (1) ES455691A1 (cs)
FI (1) FI63226C (cs)
FR (1) FR2340311A1 (cs)
GB (1) GB1550545A (cs)
HU (1) HU173483B (cs)
IE (1) IE44339B1 (cs)
IL (1) IL51316A (cs)
LU (1) LU76706A1 (cs)
NL (1) NL7700841A (cs)
NO (1) NO142625C (cs)
PL (1) PL105526B1 (cs)
PT (1) PT66154B (cs)
SE (1) SE7701187L (cs)
ZA (1) ZA77248B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
WO2006062917A2 (en) * 2004-12-06 2006-06-15 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as cancer vaccine adjuvants
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
EP2240195A4 (en) * 2007-12-12 2011-12-21 Sciclone Pharmaceuticals Inc TREATMENT OF MELANOMA WITH ALPHA-THYMOSIN PEPTIDES IN ASSOCIATION WITH ANTIBODIES AGAINST ANTIGEN 4 ASSOCIATED WITH CYTOTOXIC LYMPHOCYTE T (CTLA4)
AU2008335025A1 (en) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
AU2008338594A1 (en) * 2007-12-14 2009-06-25 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (HSAA)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
CN102458470B (zh) * 2009-05-08 2016-01-20 赛生制药有限公司 作为疫苗增强剂的α胸腺素肽
AU2015335979B2 (en) 2014-10-21 2021-05-20 Sciclone Pharmaceuticals International (Sg) Pte. Ltd. Treatment of cancer with immune stimulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines

Also Published As

Publication number Publication date
CA1094560A (en) 1981-01-27
FI770398A7 (cs) 1977-08-08
DK138891B (da) 1978-11-13
FI63226B (fi) 1983-01-31
JPS52105186A (en) 1977-09-03
PL105526B1 (pl) 1979-10-31
DE2604845A1 (de) 1977-08-18
BE850492A (fr) 1977-07-18
PT66154B (fr) 1978-07-07
NO770374L (no) 1977-08-09
HU173483B (hu) 1979-05-28
US4079137A (en) 1978-03-14
IL51316A0 (en) 1977-03-31
CH631448A5 (de) 1982-08-13
NL7700841A (nl) 1977-08-09
IE44339B1 (en) 1981-10-21
DK138891C (da) 1979-04-23
ZA77248B (en) 1977-11-30
PT66154A (fr) 1977-03-01
FR2340311B1 (cs) 1980-02-08
IE44339L (en) 1977-08-07
DD128133A5 (de) 1977-11-02
FR2340311A1 (fr) 1977-09-02
NO142625B (no) 1980-06-09
GB1550545A (en) 1979-08-15
AU504526B2 (en) 1979-10-18
DK49077A (da) 1977-08-08
AU2195277A (en) 1978-08-10
AT355578B (de) 1980-03-10
LU76706A1 (cs) 1977-06-28
ES455691A1 (es) 1978-01-01
IL51316A (en) 1980-12-31
FI63226C (fi) 1983-05-10
ATA68177A (de) 1979-08-15
NO142625C (no) 1980-09-17
CS201544B2 (en) 1980-11-28

Similar Documents

Publication Publication Date Title
SE8402549L (sv) Substituerade moranolinderivat
SE425715B (sv) Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdom
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
NL190160C (nl) Piperazinecarboxamide- en -carbothioamidederivaten, werkwijze ter bereiding daarvan, alsmede farmaceutisch preparaat dat een dergelijk derivaat omvat.
SE7707462L (sv) Forfarande for framstellning av penicillansyraderivat
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
PT69582A (fr) Nouveaux acides lactame-n-acetiques et leurs amides leurs procedes de preparation et compositions pharmaceutiques
SE7705143L (sv) Nya omega-aminokarboxylsyraamider jemte sett for deras framstellning
DK148183A (da) Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
GB1492528A (en) Pyrazinyl piperazine derivatives
SE7901493L (sv) Nya amidderivat av 5-pyrimidin-karbonsyror och sett for deras framstellning och anvendning som lekemedel
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7411243L (cs)
SE7811455L (sv) 2-imino-imidazolidin-derivat
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
NO167978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
SE8005687L (sv) Nya 10-halogen-e-homoeburnaner jemte sett for deras framstellning
DK486879A (da) Fremgangsmaade til fremstilling af aminopropanolderivater af 6-hydroxy-2,3,4,5-tetrahydro-1h-1-benzazepin-2-on eller syreadditionssalte deraf
SE7701186L (sv) Alkylendioxidpiperazinderivat och sett att framstella desamma
NO150435C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylamino-imidazolin-derivater
ES440208A1 (es) Procedimiento para la fabricacion de derivados de piperazi- na.
FI820172L (fi) Basiskt substituerade antranilsyror deras framstaellningsfoerfarande och anvaendning
SE7602760L (sv) Monosubstituerat piperazinderivat
SE7701504L (sv) Antihypertensiva medel

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7701187-2

Format of ref document f/p: F